Aspirin-/TMZ-coloaded Microspheres Exert Synergistic Antiglioma Efficacy via Inhibition of β-catenin Transactivation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspirin-/TMZ-coloaded Microspheres Exert Synergistic Antiglioma Efficacy via Inhibition of β-catenin Transactivation
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 19, Issue 2, Pages 98-108
Publisher
Wiley
Online
2012-12-12
DOI
10.1111/cns.12041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-21 Expression is regulated by β-catenin/STAT3 Pathway and Promotes Glioma Cell Invasion by Direct Targeting RECK
- (2012) Lei Han et al. CNS Neuroscience & Therapeutics
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Nuclear Translocation of β-catenin is Essential for Glioma Cell Survival
- (2012) Zhendong Shi et al. Journal of Neuroimmune Pharmacology
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
- (2012) Xiaomin Qian et al. MOLECULAR PHARMACEUTICS
- VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling
- (2012) Lingchao Chen et al. NEURO-ONCOLOGY
- Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats
- (2012) Gui-Ke Zou et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- β-catenin and Gli1 are prognostic markers in glioblastoma
- (2011) Marco Rossi et al. CANCER BIOLOGY & THERAPY
- Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients
- (2011) Sameer Agnihotri et al. JOURNAL OF CLINICAL INVESTIGATION
- Insulin-loaded PLGA microparticles: flow focusingversusdouble emulsion/solvent evaporation
- (2011) M. J. Cózar-Bernal et al. JOURNAL OF MICROENCAPSULATION
- Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres
- (2011) C. Presmanes et al. JOURNAL OF MICROENCAPSULATION
- Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas
- (2011) Kazuya Motomura et al. JOURNAL OF NEURO-ONCOLOGY
- Antitumor effect of aspirin in glioblastoma cells by modulation of β-catenin/T-cell factor–mediated transcriptional activity
- (2011) Fengming Lan et al. JOURNAL OF NEUROSURGERY
- A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
- (2011) Atique U. Ahmed et al. MOLECULAR PHARMACEUTICS
- Paclitaxel/Tetrandrine Coloaded Nanoparticles Effectively Promote the Apoptosis of Gastric Cancer Cells Based on “Oxidation Therapy”
- (2011) Xiaolin Li et al. MOLECULAR PHARMACEUTICS
- High -catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression
- (2011) J. Zhang et al. NEURO-ONCOLOGY
- Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
- (2011) G. Prasad et al. NEURO-ONCOLOGY
- Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3β/β-Catenin Signaling Pathway
- (2011) Cuixian Li et al. PLoS One
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells
- (2010) Xiao Yue et al. BRAIN RESEARCH
- MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature
- (2010) N. Gaspar et al. CANCER RESEARCH
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres
- (2010) Fengying Sun et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Analysis and stability study of temozolomide using capillary electrophoresis
- (2010) Melinda Andrasi et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Aspirin Intake and Survival After Breast Cancer
- (2010) Michelle D. Holmes et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Use and Survival After Diagnosis of Colorectal Cancer
- (2009) Andrew T. Chan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
- (2008) Liangfang Zhang et al. ACS Nano
- Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators
- (2008) H.-W. Lo et al. CLINICAL CANCER RESEARCH
- Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
- (2008) J. N. Sarkaria et al. CLINICAL CANCER RESEARCH
- Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
- (2008) Tobias Sinnberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition
- (2008) S. Caporali et al. MOLECULAR PHARMACOLOGY
- Mechanisms of Disease: temozolomide and glioblastoma—look to the future
- (2008) Maciej M Mrugala et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started